Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
02/2008
02/21/2008US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
02/21/2008US20080045504 Benzonitrile Derivatives to Treat Musculoskeletal Frailty
02/21/2008US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2008US20080045497 Substituted aniline derivatives
02/21/2008US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
02/21/2008US20080045470 Ceramides and Apoptosis-Signaling Ligand
02/21/2008DE102006039003A1 Neue Verbindungen New connections
02/21/2008CA2660953A1 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo [1,5-a] pyrimidine derivatives using same
02/21/2008CA2658960A1 Phenyl, pyridine and quinoline derivatives
02/20/2008EP1889845A1 Novel pleuromutilin derivatives
02/20/2008EP1889835A1 Cyclic amine derivative having substituted alkyl group
02/20/2008EP1889829A1 Nonsteroic androgen acceptor regulators, preparation process, pharmaceutical composition and use thereof
02/20/2008EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
02/20/2008EP1888528A2 Phosphodiesterase 4 inhibitors
02/20/2008EP1888527A1 Piperidines for the treatment of chemokine mediated diseases
02/20/2008EP1888526A1 Piperidines for the treatment of chemokine mediated diseases
02/20/2008EP1436271B1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
02/20/2008EP1131290B1 Piperidine ccr-3 receptor antagonists
02/20/2008CN101128427A Heterocyclic compounds as ccr2b antagonists
02/20/2008CN101128423A Novel lipoxygenase inhibitors
02/20/2008CN101128421A Methods and compositions for treating amyloid-related diseases
02/20/2008CN101125830A Piperidines compounds for preparing olefin polymerization catalyst
02/20/2008CN100369906C Method for producing 3-amidinophenylalanine derivatives
02/20/2008CN100369897C Diastereomeric salts of terfenadine
02/20/2008CN100369896C Cyclic amino compounds
02/20/2008CN100369888C N-alkanoylphenylalanine derivatives
02/19/2008US7332607 Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
02/19/2008US7332606 senile dementias; subjecting 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-ylidene]methyl-piperidine or a solvate thereof to catalytic hydrogenation in the presence of a palladium-alumina catalyst
02/19/2008US7332508 heterocyclic amines such as 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine and salts, used as histamine-H3 receptor antagonists for treatment of nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders
02/19/2008US7332504 Heterocyclic substituted aminoazacycles useful as central nervous system agents
02/19/2008US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders
02/19/2008US7332487 Nitrogen-containing 5-membered ring compound
02/19/2008CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines
02/14/2008WO2007117560A8 Piperidine and morpholine renin inhibitors
02/14/2008US20080039633 Process for preparing arylamines
02/14/2008US20080039631 Process For Preparing N-(Substituted Arylmethyl) -4-Substituted-4-(Disubstituted Methyl) Piperidines And Intermediates
02/14/2008US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity
02/14/2008US20080039498 Non-competitive NMDA receptor antagonists
02/14/2008US20080039446 Substituted isoindoles and their use
02/14/2008DE102006037399A1 Verfahren zur Herstellung von Arylaminen A process for the preparation of arylamines
02/13/2008EP1886994A1 Cyclic amine compounds as CCR5 antagonists
02/13/2008EP1885696A1 Glycosidase-inhibiting iminosugars
02/13/2008EP1536796B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
02/13/2008EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists
02/13/2008EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
02/13/2008EP1401816B1 Process for the production of the piperidine derivative fexofenadine
02/13/2008EP1313703B1 Prodrugs to nmda receptor ligands
02/13/2008CN101124204A Amorphous lercanidipine hydrochloride
02/13/2008CN101124203A Chemical compounds
02/13/2008CN101124201A Parp抑制剂 Parp inhibitors
02/13/2008CN101124199A 5-substituted-2-phenylamino-benzamide as MEK inhibitor
02/13/2008CN101121693A Lercanidipine hydrochloride crystal and preparation method thereof
02/13/2008CN101121692A Synthesis method for alpha-carbonylamide compound
02/13/2008CN100368401C Cyanoguanidine prodrugs
02/13/2008CN100368392C Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation
02/12/2008US7329770 Esters as useful broad spectrum herbicidal compounds
02/12/2008US7329767 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
02/12/2008US7329755 especially naphthalene sulfonamides, used for treating asthma
02/12/2008US7329656 Arylthiobenzylpiperidine derivatives
02/12/2008CA2385996C Anticancer agents
02/12/2008CA2258701C Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
02/07/2008WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR
02/07/2008WO2008015248A1 Process for preparing amorphous lercanidipine hydrochloride
02/07/2008WO2007098826A3 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
02/07/2008WO2007035722B1 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
02/07/2008WO2006105304A8 Phenyl and pyridyl lta4h modulators
02/07/2008WO2006005455A3 Amino, amino acid or peptide conjugates of retinoic acid
02/07/2008US20080033180 Condensing an enone with an alkylthioenamine, cyclizing in the presence of ammonia; high yield; intermediates for novel insecticides
02/07/2008US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
02/07/2008US20080033016 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them
02/07/2008US20080033015 Histone Deacetylase Inhibitors
02/07/2008US20080032993 Substituted heterocyclic compounds
02/07/2008US20080032978 Soluble epoxide hydrolase inhibitors
02/06/2008EP1883628A2 Improved process for the preparation of 3,5-diethyl-1,2-dihydro-1-phenyl-2-propylpyridine
02/06/2008EP1883402A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
02/06/2008CN101119717A Substituted phenols as active agents inhibiting vegf production
02/06/2008CN101117330A Tartrate of isofagomine and use thereof
02/06/2008CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/06/2008CN100366252C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion
02/05/2008US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance
02/05/2008US7326723 Autoimmune disease; antiinflammatory agents
02/05/2008US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy
02/05/2008US7326720 Phenyl- and pyridylpiperidines with TNF activity
02/05/2008US7326719 Cathepsin S inhibitors
02/05/2008US7326716 Treatment of inflammatory bowel disease
02/05/2008US7326696 Amino-methyl substituted tetracycline compounds
01/2008
01/31/2008WO2008013248A1 Process for production of (±)-trans-4-(4- fluorophenyl)-3-hydroxymethylpiperidine
01/31/2008WO2008012859A2 Process for preparing fexofenadine
01/31/2008WO2008012858A1 Process for preparing fexofenadine
01/31/2008WO2008012524A1 Substituted aniline derivatives
01/31/2008US20080027230 reacting an onium chloride with an acid resulting in formation of hydrochloric acid, formed hydrochloric acid is removed by azeotropic distillation by coordination to 1,4-dioxane which forms an azeotropic mixture with water;
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027227 reacting amlodipine with nicotinic acid in an organic solvent to form amlodipine nicotinate salt; and recrystallizing formed salt with a mixture of solvents containing methanol and isopropanol or water and isopropanol Photostability; enhanced pharmacological activity
01/31/2008US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia
01/31/2008US20080027108 Therapeutic substituted lactams
01/31/2008US20080027107 With nitrogen containing heterocyclic substituents; for example, 1-{[(2-dimethylamino)ethyl]amino}-4-{[2-(3-hydroxypiperidin-1-yl)ethyl]amino}-anthracene-9,10-dione
01/31/2008US20080027096 Novel Pharmaceutical Compositions
01/31/2008US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
01/31/2008US20080027066 Arylpiperazinyl Compounds